vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM). Click either name above to swap in a different company.
Arbutus Biopharma Corp is the larger business by last-quarter revenue ($10.7M vs $6.1M, roughly 1.8× INTELLIGENT PROTECTION MANAGEMENT CORP.). On growth, INTELLIGENT PROTECTION MANAGEMENT CORP. posted the faster year-over-year revenue change (2091.6% vs 522.2%). Over the past eight quarters, INTELLIGENT PROTECTION MANAGEMENT CORP.'s revenue compounded faster (54.7% CAGR vs -13.2%).
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
Intelligent Limited is a Holding Company and Parent company headquartered in Gloucestershire, United Kingdom and was incorporated on 21 May 2008. Intelligent Limited provides a group management structure for four companies and was born out of the operations of International Intelligence Limited, a company specialising in Intelligence, Counter Espionage and TSCM sweeping.
ABUS vs IPM — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $6.1M |
| Net Profit | $2.5M | — |
| Gross Margin | — | 53.1% |
| Operating Margin | 13.9% | -13.4% |
| Net Margin | 23.5% | — |
| Revenue YoY | 522.2% | 2091.6% |
| Net Profit YoY | 112.7% | — |
| EPS (diluted) | $0.01 | $-0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.1M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | $10.7M | $5.7M | ||
| Q1 25 | — | $5.5M | ||
| Q4 23 | $2.1M | $-7.3M | ||
| Q3 23 | $4.7M | $2.8M | ||
| Q2 23 | $4.7M | $3.0M | ||
| Q1 23 | $6.7M | $2.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.1M | ||
| Q2 25 | $2.5M | $-1.1M | ||
| Q1 25 | — | $808.5K | ||
| Q4 23 | — | — | ||
| Q3 23 | $-20.1M | $-181.6K | ||
| Q2 23 | $-17.1M | $135.6K | ||
| Q1 23 | $-16.3M | $-738.3K |
| Q4 25 | — | 53.1% | ||
| Q3 25 | — | 50.7% | ||
| Q2 25 | — | 50.1% | ||
| Q1 25 | — | 55.3% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 70.1% | ||
| Q2 23 | — | 73.8% | ||
| Q1 23 | — | 68.7% |
| Q4 25 | — | -13.4% | ||
| Q3 25 | — | -23.0% | ||
| Q2 25 | 13.9% | -19.7% | ||
| Q1 25 | — | -24.2% | ||
| Q4 23 | -967.2% | — | ||
| Q3 23 | -462.8% | -14.1% | ||
| Q2 23 | -395.3% | -9.4% | ||
| Q1 23 | -260.4% | -35.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | -17.4% | ||
| Q2 25 | 23.5% | -18.3% | ||
| Q1 25 | — | 14.7% | ||
| Q4 23 | — | — | ||
| Q3 23 | -431.6% | -6.6% | ||
| Q2 23 | -367.5% | 4.6% | ||
| Q1 23 | -244.3% | -28.8% |
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | $0.01 | $-0.08 | ||
| Q1 25 | — | $0.06 | ||
| Q4 23 | $-0.12 | $-0.03 | ||
| Q3 23 | $-0.12 | $-0.02 | ||
| Q2 23 | $-0.10 | $0.01 | ||
| Q1 23 | $-0.10 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $5.6M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $83.0M | $18.2M |
| Total Assets | $103.3M | $26.0M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.6M | ||
| Q3 25 | — | $7.3M | ||
| Q2 25 | $37.4M | $7.3M | ||
| Q1 25 | — | $9.7M | ||
| Q4 23 | $126.0M | $13.6M | ||
| Q3 23 | $17.5M | $13.7M | ||
| Q2 23 | $27.2M | $13.7M | ||
| Q1 23 | $40.6M | $13.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q4 23 | $0 | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | — | ||
| Q1 23 | $0 | — |
| Q4 25 | — | $18.2M | ||
| Q3 25 | — | $18.8M | ||
| Q2 25 | $83.0M | $19.9M | ||
| Q1 25 | — | $21.1M | ||
| Q4 23 | $106.0M | $20.1M | ||
| Q3 23 | $119.3M | $20.4M | ||
| Q2 23 | $134.7M | $20.5M | ||
| Q1 23 | $143.9M | $20.3M |
| Q4 25 | — | $26.0M | ||
| Q3 25 | — | $27.2M | ||
| Q2 25 | $103.3M | $29.8M | ||
| Q1 25 | — | $31.1M | ||
| Q4 23 | $144.4M | $23.9M | ||
| Q3 23 | $158.6M | $24.1M | ||
| Q2 23 | $176.8M | $24.4M | ||
| Q1 23 | $191.2M | $24.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 23 | 0.00× | — | ||
| Q3 23 | 0.00× | — | ||
| Q2 23 | 0.00× | — | ||
| Q1 23 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $87.6K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | -6.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $87.6K | ||
| Q3 25 | — | $133.0K | ||
| Q2 25 | $-15.7M | $-888.7K | ||
| Q1 25 | — | $1.7M | ||
| Q4 23 | $-17.3M | $-99.0K | ||
| Q3 23 | $-21.8M | $16.1K | ||
| Q2 23 | $-19.6M | $-193.8K | ||
| Q1 23 | $-27.3M | $-803.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-21.8M | — | ||
| Q2 23 | $-20.4M | — | ||
| Q1 23 | $-27.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -468.4% | — | ||
| Q2 23 | -439.0% | — | ||
| Q1 23 | -410.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | — | — | ||
| Q4 23 | 0.0% | — | ||
| Q3 23 | 0.7% | — | ||
| Q2 23 | 18.5% | — | ||
| Q1 23 | 1.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | 2.16× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -1.43× | ||
| Q1 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABUS
Segment breakdown not available.
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
